The Polymorphisms in Methylenetetrahydrofolate Reductase, Methionine Synthase, Methionine Synthase Reductase, and the Risk of Colorectal Cancer

Polymorphisms in genes involved in folate metabolism may modulate the risk of colorectal cancer (CRC), but data from published studies are conflicting. The current meta-analysis was performed to address a more accurate estimation. A total of 41 (17,552 cases and 26,238 controls), 24(8,263 cases and 12,033 controls), 12(3,758 cases and 5,646 controls), and 13 (5,511 cases and 7,265 controls) studies were finally included for the association between methylenetetrahydrofolate reductase (MTHFR) C677T and A1289C, methione synthase reductase (MTRR) A66G, methionine synthase (MTR) A2756G polymorphisms and the risk of CRC, respectively. The data showed that the MTHFR 677T allele was significantly associated with reduced risk of CRC (OR = 0.93, 95%CI 0.90-0.96), while the MTRR 66G allele was significantly associated with increased risk of CRC (OR = 1.11, 95%CI 1.01-1.18). Sub-group analysis by ethnicity revealed that MTHFR C677T polymorphism was significantly associated with reduced risk of CRC in Asians (OR = 0.80, 95%CI 0.72-0.89) and Caucasians (OR = 0.84, 95%CI 0.76-0.93) in recessive genetic model, while the MTRR 66GG genotype was found to significantly increase the risk of CRC in Caucasians (GG vs. AA: OR = 1.18, 95%CI 1.03-1.36). No significant association was found between MTHFR A1298C and MTR A2756G polymorphisms and the risk of CRC. Cumulative meta-analysis showed no particular time trend existed in the summary estimate. Probability of publication bias was low across all comparisons illustrated by the funnel plots and Egger's test. Collectively, this meta-analysis suggested that MTHFR 677T allele might provide protection against CRC in worldwide populations, while MTRR 66G allele might increase the risk of CRC in Caucasians. Since potential confounders could not be ruled out completely, further studies were needed to confirm these results.

[1]  K. Brčić-Kostić,et al.  Association of MTHFR, MTR, MTRR, RFC1, and DHFR gene polymorphisms with susceptibility to sporadic colon cancer. , 2011, DNA and cell biology.

[2]  S. Mudassar,et al.  Risk of colorectal cancer associated with the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the Kashmiri population. , 2011, Genetics and molecular research : GMR.

[3]  C. Coy,et al.  Gene polymorphisms involved in folate and methionine metabolism and increased risk of sporadic colorectal adenocarcinoma , 2011, Tumor Biology.

[4]  K. Hemminki,et al.  MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from the Czech Republic. , 2011, Mutation research.

[5]  L. Cui,et al.  Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer in a Korean population , 2010, BMC Cancer.

[6]  A. Fernández-Peralta,et al.  Association of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy , 2010, International Journal of Colorectal Disease.

[7]  L. Marchand,et al.  Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. , 2009, American journal of epidemiology.

[8]  M. Zali,et al.  Reverse association between MTHFR polymorphism (C677T) with sporadic colorectal cancer , 2009 .

[9]  J. Little,et al.  Polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene, intakes of folate and related B vitamins and colorectal cancer: a case–control study in a population with relatively low folate intake , 2008, British Journal of Nutrition.

[10]  A. Tenesa,et al.  Dietary Vitamin B6 Intake and the Risk of Colorectal Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[11]  I. Yaylim,et al.  Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer , 2007, Cell biochemistry and function.

[12]  F. Costa,et al.  Polymorphisms in methylenetetrahydrofolate reductase gene (MTHFR) and the age of onset of sporadic colorectal adenocarcinoma , 2007, International Journal of Colorectal Disease.

[13]  Shung-Haur Yang,et al.  Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers , 2007, International Journal of Colorectal Disease.

[14]  W. Willett,et al.  Nonsynonymous Polymorphisms in Genes in the One-Carbon Metabolism Pathway and Associations with Colorectal Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[15]  R. Houlston,et al.  MTHFR C677T and colorectal cancer risk: A meta‐analysis of 25 populations , 2006, International journal of cancer.

[16]  Y. Huang,et al.  Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis , 2006, Journal of Human Genetics.

[17]  Roger M Harbord,et al.  A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints , 2006, Statistics in medicine.

[18]  E. Riboli,et al.  Low folate levels may protect against colorectal cancer , 2006, Gut.

[19]  Seiichi Nakamura,et al.  Associations between 5,10‐methylenetetrahydrofolate reductase codon 677 and 1298 genetic polymorphisms and environmental factors with reference to susceptibility to colorectal cancer: A case‐control study in an Indian population , 2006, International journal of cancer.

[20]  K. Matsuo,et al.  One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. , 2005, Carcinogenesis.

[21]  Teruhiko Yoshida,et al.  Folate, Vitamin B6, Vitamin B12, and Vitamin B2 Intake, Genetic Polymorphisms of Related Enzymes, and Risk of Colorectal Cancer in a Hospital-Based Case-Control Study in Japan , 2005, Nutrition and cancer.

[22]  S. Kono,et al.  Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma , 2005, Cancer science.

[23]  B. Henderson,et al.  The MTHFR C677T Polymorphism and Colorectal Cancer: The Multiethnic Cohort Study , 2005, Cancer Epidemiology Biomarkers & Prevention.

[24]  J. Stempak,et al.  Cell and stage of transformation-specific effects of folate deficiency on methionine cycle intermediates and DNA methylation in an in vitro model. , 2005, Carcinogenesis.

[25]  S. Kono,et al.  Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea. , 2004, Cancer letters.

[26]  S. Vollset,et al.  Colorectal cancer and the methylenetetrahydrofolate reductase 677C -> T and methionine synthase 2756A -> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  Jian Yu,et al.  Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. , 2004, World Journal of Gastroenterology.

[28]  Y. Kakeji,et al.  Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: The Fukuoka Colorectal Cancer Study , 2004, Cancer science.

[29]  C. Ulrich,et al.  Methionine Synthase D919G Polymorphism, Folate Metabolism, and Colorectal Adenoma Risk , 2004, Cancer Epidemiology Biomarkers & Prevention.

[30]  T. Sanders,et al.  Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. , 2003, Gastroenterology.

[31]  J. Boer,et al.  A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. , 2003, Cancer research.

[32]  H. Schackert,et al.  Methylenetetrahydrofolate reductase polymorphisms and risk of sporadic and hereditary colorectal cancer with or without microsatellite instability. , 2003, Cancer letters.

[33]  R. Gafà,et al.  Methylenetetrahydrofolate reductase 677 C-->T polymorphism and risk of proximal colon cancer in north Italy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  J. Barrett,et al.  A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. , 2002, Carcinogenesis.

[35]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[36]  D. Hunter,et al.  Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. , 2002, Pharmacogenetics.

[37]  L. Kolonel,et al.  B-vitamin intake, metabolic genes, and colorectal cancer risk (United States) , 2002, Cancer Causes & Control.

[38]  J. Beilby,et al.  A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability , 2002, Gut.

[39]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[40]  A. Evans,et al.  The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. , 2001, Atherosclerosis.

[41]  J H Eckfeldt,et al.  The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. , 2001, Atherosclerosis.

[42]  M. Leppert,et al.  Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[43]  J F Gregory,et al.  Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. , 1999, The Journal of nutrition.

[44]  Aaron D. Wilson,et al.  Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  P. Jones,et al.  Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. , 1997, Carcinogenesis.

[46]  W. Willett,et al.  Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. , 1997, Cancer research.

[47]  P. Goyette,et al.  Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. , 1996, Human molecular genetics.

[48]  E. Rimm,et al.  A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. , 1996, Cancer research.

[49]  E. Rimm,et al.  Folate, methionine, and alcohol intake and risk of colorectal adenoma. , 1993, Journal of the National Cancer Institute.

[50]  T C Chalmers,et al.  Cumulative meta-analysis of therapeutic trials for myocardial infarction. , 1992, The New England journal of medicine.

[51]  Xinyuan Ma,et al.  Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. , 2005, Cancer detection and prevention.

[52]  KunChen,et al.  Relationship between metabolic enzyme polymorphism and colorectal cancer , 2005 .

[53]  Cancer Epidemiol Biomarkers Prev , 2004 .

[54]  K. Matsuo,et al.  Methionine Synthase Reductase Gene A66G Polymorphism is Associated with Risk of Colorectal Cancer. , 2002, Asian Pacific journal of cancer prevention : APJCP.

[55]  Christopher F. Martin,et al.  5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[56]  松尾 恵太郎.  Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma , 2002 .

[57]  Dermot Kelleher,et al.  The methylenetetrahydrofolate reductase (MTHFR) gene in colorectal cancer , 2001, International journal of gastrointestinal cancer.

[58]  J. Mok,et al.  The 677C > T mutation in 5,10-methylenetetrahydrofolate reductase and colorectal cancer risk. , 1999, Genetic testing.

[59]  A. Tobías.  Assessing the influence of a single study in the meta-anyalysis estimate , 1999 .

[60]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.